Protsyk Volodymyr, Rasmussen Bodil Steen, Guarracino Fabio, Erb Joachim, Turton Edwin, Ender Joerg
Department of Anesthesiology and Intensive Care Medicine, Heart Center Leipzig, Leipzig, Germany.
Department of Anesthesia and Intensive Care Medicine, Aalborg University Hospital, Aalborg, Denmark.
J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1624-1629. doi: 10.1053/j.jvca.2017.04.017. Epub 2017 Apr 13.
To evaluate the current practice of perioperative fluid management in cardiac surgery patients.
Multiple choice survey with 26 questions about existing practice of perioperative fluid management in cardiac surgery patients.
Online survey.
Representatives of anesthesia departments in European cardiac surgical centers.
None.
The study comprised 106 respondents from 18 European countries who mainly worked in teaching hospitals (66%). In 73% of institutions, patients were admitted to a cardiac surgery intensive care unit (ICU) postoperatively. Perfusionists were responsible for the cardiopulmonary bypass priming solution, whereas anesthesiologists were responsible for intraoperative and postoperative fluid management. For cardiopulmonary bypass priming, balanced crystalloids were used in 51.5% of the centers, whereas in 36%, a combination of crystalloid with either synthetic colloid or albumin was administered. Intraoperatively, balanced crystalloids were used by 74% of centers, followed by a combination of crystalloids with synthetic colloids (15%) and other combinations (11%). No colloids were used by 32% of respondents. When colloids were used, gelatin was preferred, compared with hydroxyethyl starches and albumin (60% v 24% v 16%, respectively). Seventy-three percent of respondents, also involved in ICU treatment, did not change their fluid strategy in the ICU compared with their intraoperative strategy. Thirty-two percent of those who changed their strategy either added (32%) or decreased (29%) synthetic colloids or added (32%) or decreased (7%) natural colloids.
Perioperative fluid management in cardiac surgery patients may have changed in the last few years in European centers. Balanced crystalloids now seem to be the preferred solutions, followed by synthetic colloids (mainly gelatins) and albumin.
评估心脏手术患者围手术期液体管理的当前实践情况。
针对心脏手术患者围手术期液体管理现有实践的26个问题的多项选择调查。
在线调查。
欧洲心脏外科中心麻醉科代表。
无。
该研究包括来自18个欧洲国家的106名受访者,他们主要在教学医院工作(66%)。在73%的机构中,患者术后被收入心脏外科重症监护病房(ICU)。灌注师负责体外循环预充液,而麻醉医生负责术中及术后的液体管理。对于体外循环预充,51.5%的中心使用平衡晶体液,而36%的中心使用晶体液与合成胶体或白蛋白的组合。术中,74%的中心使用平衡晶体液,其次是晶体液与合成胶体的组合(15%)以及其他组合(11%)。32%的受访者未使用胶体。当使用胶体时,与羟乙基淀粉和白蛋白相比,明胶更受青睐(分别为60%对24%对16%)。73%同时参与ICU治疗的受访者在ICU中的液体策略与术中策略相比没有改变。改变策略的受访者中,32%增加(32%)或减少(29%)合成胶体,或增加(32%)或减少(7%)天然胶体。
在过去几年中,欧洲心脏手术患者围手术期液体管理可能已发生变化。目前平衡晶体液似乎是首选溶液,其次是合成胶体(主要是明胶)和白蛋白。